Overexpression of Dehydrogenase/Reductase 9 Predicts Poor Response to Concurrent Chemoradiotherapy and Poor Prognosis in Rectal Cancer Patients

Objective: To reduce the risk of locoregional recurrence, the addition of neoadjuvant concurrent chemoradiotherapy (CCRT) is recommended before surgical management for rectal cancer patients. However, despite identical tumor histology, individual patient response to neoadjuvant CCRT varies greatly....

Descrición completa

Detalles Bibliográficos

Principais autores:	Tzu-Ju Chen, Bei-Hao Hsu, Sung-Wei Lee, Ching-Chieh Yang, Yu-Feng Tian, Yu-Hsuan Kuo, Wan-Shan Li, Hsin-Hwa Tsai, Li-Ching Wu, Cheng-Fa Yeh, Chia-Lin Chou, Hong-Yue Lai
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2022-10-01
Series:	Pathology and Oncology Research
Assuntos:	biomarker rectal cancer DHRS9 epithelial cell differentiation keratan sulfate mucin
Acceso en liña:	https://www.por-journal.com/articles/10.3389/pore.2022.1610537/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!